Bladder Tumors and other Topics in Urological Oncology: Ettore Majorana International Science Series, cartea 1
Editat de M. Pavone-Macalusoen Limba Engleză Paperback – 26 noi 2012
Din seria Ettore Majorana International Science Series
- Preț: 384.75 lei
- 18% Preț: 771.62 lei
- Preț: 391.88 lei
- Preț: 396.38 lei
- Preț: 394.68 lei
- 5% Preț: 360.19 lei
- 5% Preț: 1067.46 lei
- Preț: 404.94 lei
- Preț: 399.17 lei
- 15% Preț: 618.71 lei
- Preț: 417.10 lei
- Preț: 375.03 lei
- Preț: 389.61 lei
- Preț: 387.77 lei
- Preț: 379.72 lei
- Preț: 390.94 lei
- Preț: 387.01 lei
- 15% Preț: 636.99 lei
- 18% Preț: 904.84 lei
- Preț: 386.44 lei
- Preț: 364.94 lei
- Preț: 370.38 lei
- Preț: 371.49 lei
- Preț: 382.89 lei
- 15% Preț: 631.43 lei
- Preț: 390.94 lei
- Preț: 389.46 lei
- 15% Preț: 637.62 lei
- 18% Preț: 1184.90 lei
- Preț: 379.72 lei
- Preț: 381.20 lei
- Preț: 394.85 lei
- Preț: 365.35 lei
- Preț: 423.44 lei
- 5% Preț: 377.77 lei
- 18% Preț: 1191.03 lei
- Preț: 407.21 lei
- 5% Preț: 1381.44 lei
- Preț: 399.17 lei
- Preț: 381.20 lei
- 5% Preț: 372.63 lei
- 15% Preț: 641.76 lei
- Preț: 386.64 lei
- Preț: 396.18 lei
- Preț: 389.98 lei
Preț: 375.65 lei
Preț vechi: 395.42 lei
-5% Nou
Puncte Express: 563
Preț estimativ în valută:
71.89€ • 75.61$ • 59.88£
71.89€ • 75.61$ • 59.88£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461330325
ISBN-10: 1461330327
Pagini: 548
Ilustrații: XVI, 528 p. 47 illus.
Greutate: 0.86 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: Springer Us
Colecția Springer
Seria Ettore Majorana International Science Series
Locul publicării:New York, NY, United States
ISBN-10: 1461330327
Pagini: 548
Ilustrații: XVI, 528 p. 47 illus.
Greutate: 0.86 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: Springer Us
Colecția Springer
Seria Ettore Majorana International Science Series
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
TNM Classification of Urological Tumors — 1978 Edition.- T Category in Renal Carcinoma.- TNM Classification in Urinary Bladder Tumors: Value of Ta Category for Noninfiltrating Exophytic Tumors.- Prednimustine.- Orgotein Efficacy in Ameliorating Side Effects Due to Radiation Therapy.- Metronidazole: A Radiosensitizer of the Hypoxic Cells.- Cis-Diammine-Dichloro-Platinum Single Drug and Combination Chemotherapy in the Treatment of Genitourinary Cancer.- The Aims and Activities of the EORTC Urological Group.- WHO Collaborating Center for Research and Treatment of Urinary Bladder and Prostatic Carcinoma.- Chemical Carcinogenesis — A Review and Personal Observations with Special Reference to the Role of Tobacco and Phenacetin in the Production of Urothelial Tumors.- Pathology of Bladder Tumors. The Urologist’s Point of View.- Newer Aspects of Research in the Field of Bladder Tumors.- Cytology of Bladder Tumors — Round Table.- Scanning and Transmission Electron Microscopy of Hyperplastic and Neoplastic Human Urothelium.- In Situ Carcinoma of the Bladder.- Primary and Secondary Carcinoma-In-Situ.- Computed Tomography of Bladder Tumors.- Transrectal Ultrasonography: Staging of Bladder Tumors.- Lymphangiography in Advanced Bladder Cancer.- Clinical Significance of Urinary CEA Estimations in the Follow-Up of Patients with Bladder Carcinoma.- Glycosaminoglycans (GAG) in the Normal and Neoplastic Urinary Bladder — Preliminary Results.- Collagenase Activity in Human Bladder Cancers.- The Copenhagen Bladder Cancer Project 1968–1971.- Factors Influencing Prognosis in Patients with Bladder Tumors.- Urinary Tract Infection in Patients with Bladder Tumor.- Adenocarcinoma of the Bladder.- to Immunology and Immunotherapy of Bladder Tumors.- Immune Response in Bladder Cancer.-Monocyte Function in Bladder Cancer.- T and B Lymphocytes in Patients with Bladder Tumors.- ABH-Antigenicity in T1 Urothelial Tumors.- Humoral and Cellular Immune Response in Patients with Transitional Cell Carcinoma of the Urinary Bladder (TCC) Against Bladder Carcinoma Cells in Tissue Culture.- Immunotherapy in Bladder Cancer.- Intravesical BCG (Bacillus Calmette-Guerin) in the Management of T1 Nx Mx Transitional Cell Tumors of the Bladder: A Toxicity Study.- BCG Vaccine in the Treatment of Noninfiltrating Papillary Tumors of the Bladder.- Transurethral Surgery.- Transurethral Resection or Cystectomy? An Attempt to Answer this Question by an Evaluation of 688 Patients with Carcinoma of the Bladder (with Special Reference to Age, Sex, Stage, and the Presence of Associated Disease).- Partial Cystectomy.- Autologous Human Skin Flaps in Partial Replacement of the Bladder Wall.- Indications for Cystectomy.- The Results of Total Cystectomy for Carcinoma of the Bladder.- Radical Cystectomy in Advanced Bladder Tumors.- Cancer of the Urethra Following Cystectomy.- Supravesical Urinary Diversion.- Treatment of the Cancer of the Bladder by Irradiation, Cystoprostatectomy and Ileocystoplasty.- A Type of Rectal Pouch for Urinary Diversion After Cystectomy.- Comparison of Bricker and Wallace Methods of Ureteroileal Anastomosis in Urinary Diversion.- Lymphadenectomy in Bladder Cancer.- Effects of Intravesical Formaldehyde-Instillation (Experimental and Clinical Results).- Hydrostatic Pressure Technique and Intravesical Instillation of Formalin: Methods for the Control of Severe Bleeding from the Bladder.- Intravesical Hyperthermia for Transitional Cell Carcinoma of the Bladder.- Hyperthermia and Bladder Cancer.- Radiotherapy in the Management of Bladder Carcinoma.- Carcinoma of theBladder Category T3 Nx, 0–4 MO Treated by Preoperative Irradiation Followed by Cystectomy at the Rotterdam Radiotherapy Institute.- Surgical Treatment of 8l Deep Infiltrating Bladder Tumors after Preoperative Irradiation.- Cystectomy Following Full Course Irradiation.- Complications of Irradiation of Urological Tumors.- Post-Diversion, Pre-Cystectomy Irradiation for Transitional Cell Carcinoma of the Bladder.- Treatment of Malignant Tumors of the Bladder by Iridium 192 Wiring.- Carcinoma of the Urinary Bladder Treated by Interstitial Radium Implant.- Radioactive Source Implantation in Bladder Tumors.- Intravesical Treatment of Superficial Urinary Bladder Tumors with Adriamycin.- Intravesical Therapy with Adriamycin in Patients with Superficial Bladder Tumors.- Local Treatment of Uroepithelial Bladder Tumors with Adriamycin.- Adriamycin Therapy in Carcinoma in Situ: A Preliminary Report.- Bladder Instillation of Adriamycin in Multiple Recurrent Non-Invasive Papillomatous Bladder Tumors.- Survival in Patients Treated with Epodyl (1968–1978).- Long-Term Intracavitary Epodyl® in Multiple or Extensive Papillary Tumors of the Urinary Bladder.- Treatment of Multiple Non-Invasive Bladder Tumors with Intravesical Epodyl®.- The Treatment of Single and Multiple Papillary Tumors of the Bladder (Ta/Tl NX MO).- Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study.- Intravesical Cis-Platinum in Bladder Tumors: Toxicity Study.- The Treatment of Bladder Cancer with Vitamin A.- The Veterans Administration Study of Chemo-Prophylaxis for Recurrent Stage I Bladder Tumors: Comparisons of Placebo, Pyridoxine, and Topical Thiotepa.- Flat Carcinoma In-Situ of the Bladder Treated by Systemic Cyclophosphamide — A Preliminary Report.- MethotrexateTherapy for Multiple Tl Category Bladder Carcinoma.- The Place of Chemotherapy in the Treatment of Patients with Invasive Carcinoma of the Bladder.- Chemotherapy in the Treatment of Invasive Bladder Cancer.- 5-Fluorouracil and Adriamycin in Locally Recurrent and/or Metastatic Bladder Cancer.- Adjuvant Chemotherapy Following Primary Irradiation in T3 Bladder Cancer.- 5-Fluorouracil in the Treatment of Recurrent Cancer of the Urinary Bladder.- Radiotherapy, Chemotherapy and Immunotherapy for Carcinoma of the Bladder.- Integrated Therapy for Invasive Bladder Carcinoma.- Cancer Chemotherapy, with Special Emphasis on the Role and Influence of Clinical Trials.- Oestrogen — Androgen Balance in Human Breast and Prostate Cancer.- Steroid Receptors in Human Prostatic Tissue.- Hormonal Receptors in Human Prostate: A Computerized Study of Normal and Pathological Tissue Samples.- Androgen Receptors in Prostatic Cancer.- Transrectal Aspiration Biopsy of the Prostate with Franzen’s Instrument.- Treatment of Prostatic Cancer with Medroxyprogesterone-Acetate (MPA).- External Irradiation of Prostatic Cancer and Indicators for Failure of Treatment.- Intraurethral Irradiation of Prostatic Cancer using Afterloading Technique.- Review of the Veterans Administration Studies of Cancer of the Prostate and New Results Concerning Treatment of Stage I and II Tumors.- Estracyt.- Combined Treatment with Bleomycin in Penile Carcinoma.- Association of Surgery and Chemotherapy in Metastatic Testicular Cancer.- Speakers.